FedEx Offers Shoppers Convenient ‘Returns’ Option – Check Out What’s New

FedEx Corp (NYSE:FDX) has launched FedEx Consolidated Returns in the U.S., a solution that offers a low-priced, easy e-commerce returns…
  • FedEx Corp (NYSE:FDX) has launched FedEx Consolidated Returns in the U.S., a solution that offers a low-priced, easy e-commerce returns option that merchants can pass on to shoppers.
  • The expanded solution, which will be launched in early 2023, is facilitated through supply chain services offered by FedEx Logistics and FedEx Office.
  • Shoppers who purchased from participating merchants can drop off the items they wish to return at approximately 2,000 FedEx Office locations.
  • The returned items will then be consolidated with other returns from various merchants, saving materials and space. 
  • “While this solution will provide a low-priced returns option for merchants, it’s also a simple, convenient process to help retailers deliver a shopper-friendly experience,” said Ryan Kelly, VP, E-Commerce & Retail Marketing, FedEx Services.
  • Price Action: FDX shares are trading higher by 1.62% at $175.11 on the last check Monday.

 

Total
0
Shares
Related Posts
Read More

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday’s Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) fell sharply during Monday’s session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic disorder causing developmental disabilities and nerve-related symptoms.

ADIL

Read More

Precigen To Present Late-Breaking Abstract For Pivotal Phase 2 Study Data For PRGN-2012 AdenoVerse Immunotherapy For The Treatment Of Patients With Recurrent Respiratory Papillomatosis At The 2024 ASCO Annual Meeting

Precigen, Inc. (NASDAQ:PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced clinical data from the pivotal Phase

PGEN